Process / pipelineClinical / epidemiology

Pragmatic Kaplan-Meier Analysis — Survival Estimation in Real-World Settings

Pragmatic Kaplan-Meier analysis applies the non-parametric Kaplan-Meier product-limit estimator to time-to-event data collected under real-world or pragmatic conditions — diverse populations, routine clinical care, minimal exclusions, and standard-of-care comparators. Unlike explanatory trials designed to isolate a treatment effect under ideal conditions, pragmatic designs accept real-world heterogeneity, and the resulting survival curves reflect the effectiveness of an intervention as it actually performs in clinical practice.

Open in MethodMindSoonVideoSoon

Read the full method

Members only

Sign in with a free account to read this section.

Sign in

Sources

  1. Kaplan, E. L., & Meier, P. (1958). Nonparametric estimation from incomplete observations. Journal of the American Statistical Association, 53(282), 457–481. DOI: 10.1080/01621459.1958.10501452
  2. Schwartz, D., & Lellouch, J. (1967). Explanatory and pragmatic attitudes in therapeutical trials. Journal of Chronic Diseases, 20(8), 637–648. DOI: 10.1016/0021-9681(67)90041-0

Related methods

ScholarGatePragmatic Kaplan-Meier analysis (Pragmatic Kaplan-Meier Survival Analysis). Retrieved 2026-06-04 from https://scholargate.app/en/epidemiology/pragmatic-kaplan-meier-analysis